Xeris Biopharma Reports Second Quarter 2026 Financial Results
Go back to Xeris Biopharma Reports Second Quarter 2026 Financial Results| (NASDAQ: XERS) | Delayed: 8.28 +0.29 (3.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.99 | 52 Week High | $ | |||
| Open | $8.00 | 52 Week Low | $ | |||
| Day High | $8.29 | P/E | N/A | |||
| Day Low | $7.96 | EPS | $ | |||
| Volume | 697,306 | |||||

